Skip to main content
NCBI home page
Journal of Neurology, Neurosurgery, and Psychiatry logoLink to Journal of Neurology, Neurosurgery, and Psychiatry
. 1986 Feb;49(2):113–123. doi: 10.1136/jnnp.49.2.113

The mystery of the origin of multiple sclerosis.

W I McDonald
PMCID: PMC1028675  PMID: 2936869

Abstract

Our present understanding of the aetiology and pathogenesis of multiple sclerosis is discussed in relation to the views of Sir William Gowers. He perceived that both environmental and genetic factors might be implicated in the aetiology of the disease. Evidence for the former was first reported in 1903, but has become convincing only in the past 20 years; the nature of the environmental factor remains obscure. Evidence for a genetic influence on susceptibility has accumulated since the 1930s, the most compelling coming from the recent Canadian twin study. The number and mode of operation of the genetic factors is still uncertain, but there is evidence for the implication of genetically controlled cellular immune mechanisms in the pathogenesis of the disease. The precise relationship between transient changes in immunological status and the development of new lesions has yet to be defined; magnetic resonance imaging (MRI) promises to play a significant role in this analysis because of its sensitivity in detecting abnormalities in multiple sclerosis. MRI is not in itself specific; it is probable that the similar appearances in multiple sclerosis and cerebral vascular disease both derive at least in part from the influence of astrocytic gliosis on proton content and distribution. The significance of the gliosis is uncertain. Gowers believed that the primary defect in multiple sclerosis lay in the astrocyte. Recent observations on the immunological functions of this cell in vitro suggest that it could be involved early in the pathogenesis of the lesion.

Full text

PDF
113

Images in this article

117Image
on p.117
118Image
on p.118

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. ADAMS J. M., IMAGAWA D. T. Measles antibodies in multiple sclerosis. Proc Soc Exp Biol Med. 1962 Dec;111:562–566. doi: 10.3181/00379727-111-27855. [DOI] [PubMed] [Google Scholar]
  2. Acheson E. D. Epidemiology of multiple sclerosis. Br Med Bull. 1977 Jan;33(1):9–14. doi: 10.1093/oxfordjournals.bmb.a071407. [DOI] [PubMed] [Google Scholar]
  3. Allen I. V. The pathology of multiple sclerosis--fact, fiction and hypothesis. Neuropathol Appl Neurobiol. 1981 May-Jun;7(3):169–182. doi: 10.1111/j.1365-2990.1981.tb00087.x. [DOI] [PubMed] [Google Scholar]
  4. Alter M., Okihiro M., Rowley W., Morris T. Multiple sclerosis among Orientals and Caucasians in Hawaii. Neurology. 1971 Feb;21(2):122–130. doi: 10.1212/wnl.21.2.122. [DOI] [PubMed] [Google Scholar]
  5. Antel J. P., Richman D. P., Medof M. E., Arnason B. G. Lymphocyte function and the role of regulator cells in multiple sclerosis. Neurology. 1978 Sep;28(9 Pt 2):106–110. doi: 10.1212/wnl.28.9_part_2.106. [DOI] [PubMed] [Google Scholar]
  6. Batchelor J. R., Compston A., McDonald W. I. The significance of the association between HLA and multiple sclerosis. Br Med Bull. 1978 Sep;34(3):279–284. doi: 10.1093/oxfordjournals.bmb.a071512. [DOI] [PubMed] [Google Scholar]
  7. Bottomley P. A., Hart H. R., Jr, Edelstein W. A., Schenck J. F., Smith L. S., Leue W. M., Mueller O. M., Redington R. W. Anatomy and metabolism of the normal human brain studied by magnetic resonance at 1.5 Tesla. Radiology. 1984 Feb;150(2):441–446. doi: 10.1148/radiology.150.2.6691099. [DOI] [PubMed] [Google Scholar]
  8. Brautbar C., Cohen I., Kahana E., Alter M., Jorgensen F., Lamm L. Histocompatibility determinants in Israeli Jewish patients with multiple sclerosis. Tissue Antigens. 1977 Oct;10(4):291–302. doi: 10.1111/j.1399-0039.1977.tb00760.x. [DOI] [PubMed] [Google Scholar]
  9. Carr D. H., Brown J., Bydder G. M., Weinmann H. J., Speck U., Thomas D. J., Young I. R. Intravenous chelated gadolinium as a contrast agent in NMR imaging of cerebral tumours. Lancet. 1984 Mar 3;1(8375):484–486. doi: 10.1016/s0140-6736(84)92852-6. [DOI] [PubMed] [Google Scholar]
  10. Compston A., Howard S. HLA typing in multiple sclerosis. Lancet. 1982 Sep 18;2(8299):661–661. doi: 10.1016/s0140-6736(82)92762-3. [DOI] [PubMed] [Google Scholar]
  11. Compston A. Lymphocyte subpopulations in patients with multiple sclerosis. J Neurol Neurosurg Psychiatry. 1983 Feb;46(2):105–114. doi: 10.1136/jnnp.46.2.105. [DOI] [PMC free article] [PubMed] [Google Scholar]
  12. DEAN G. Disseminated sclerosis in South Africa; its relationship to swayback disease and suggested treatment. Br Med J. 1949 May 14;1(4610):842–845. doi: 10.1136/bmj.1.4610.842. [DOI] [PMC free article] [PubMed] [Google Scholar]
  13. Detels R., Brody J. A., Edgar A. H. Multiple sclerosis among American, Japanese and Chinese migrants to California and Washington. J Chronic Dis. 1972 Jan;25(1):3–10. doi: 10.1016/0021-9681(72)90016-1. [DOI] [PubMed] [Google Scholar]
  14. Detels R., Visscher B. R., Malmgren R. M., Coulson A. H., Lucia M. V., Dudley J. P. Evidence for lower susceptibility to multiple sclerosis in Japanese-Americans. Am J Epidemiol. 1977 Apr;105(4):303–310. doi: 10.1093/oxfordjournals.aje.a112387. [DOI] [PubMed] [Google Scholar]
  15. Downie A. W., Phadke J. G. The chief scientist reports ... multiple sclerosis in North East Scotland. Health Bull (Edinb) 1984 May;42(3):151–156. [PubMed] [Google Scholar]
  16. Ebers G. C., Paty D. W., Stiller C. R., Nelson R. F., Seland T. P., Larsen B. HLA-typing in multiple sclerosis sibling pairs. Lancet. 1982 Jul 10;2(8289):88–90. doi: 10.1016/s0140-6736(82)91702-0. [DOI] [PubMed] [Google Scholar]
  17. Fielder A. H., Batchelor J. R., Vakarelis B. N., Compston D. A., McDonald W. I. Optic neuritis and multiple sclerosis: do factor B alleles influence progression of disease? Lancet. 1981 Dec 5;2(8258):1246–1248. doi: 10.1016/s0140-6736(81)91489-6. [DOI] [PubMed] [Google Scholar]
  18. Fontana A., Fierz W., Wekerle H. Astrocytes present myelin basic protein to encephalitogenic T-cell lines. Nature. 1984 Jan 19;307(5948):273–276. doi: 10.1038/307273a0. [DOI] [PubMed] [Google Scholar]
  19. Fontana A., Grob P. J. Astrocyte-derived interleukin-1-like factors. Lymphokine Res. 1984;3(1):11–16. [PubMed] [Google Scholar]
  20. Gilbert J. J., Sadler M. Unsuspected multiple sclerosis. Arch Neurol. 1983 Sep;40(9):533–536. doi: 10.1001/archneur.1983.04050080033003. [DOI] [PubMed] [Google Scholar]
  21. Grant I., McDonald W. I., Trimble M. R., Smith E., Reed R. Deficient learning and memory in early and middle phases of multiple sclerosis. J Neurol Neurosurg Psychiatry. 1984 Mar;47(3):250–255. doi: 10.1136/jnnp.47.3.250. [DOI] [PMC free article] [PubMed] [Google Scholar]
  22. Gyódi E., Tauszik T., Petranyi G., Kotvász A., Pálffy G., Takács I., Nemák P., Hollán S. R. The HLA antigen distribution in the Gipsy population in Hungary. Tissue Antigens. 1981 Jul;18(1):1–12. doi: 10.1111/j.1399-0039.1981.tb01355.x. [DOI] [PubMed] [Google Scholar]
  23. Haire M. Significance of virus antibodies in multiple sclerosis. Br Med Bull. 1977 Jan;33(1):40–44. doi: 10.1093/oxfordjournals.bmb.a071394. [DOI] [PubMed] [Google Scholar]
  24. Hornabrook R. W. The prevalence of multiple sclerosis in New Zealand. Acta Neurol Scand. 1971;47(4):426–438. doi: 10.1111/j.1600-0404.1971.tb07497.x. [DOI] [PubMed] [Google Scholar]
  25. Janota I. Dementia, deep white matter damage and hypertension: 'Binswanger's disease'. Psychol Med. 1981 Feb;11(1):39–48. doi: 10.1017/s0033291700053265. [DOI] [PubMed] [Google Scholar]
  26. KURLAND L. T. The frequency and geographic distribution of multiple sclerosis as indicated by mortality statistics and morbidity surveys in the United States and Canada. Am J Hyg. 1952 May;55(3):457–481. doi: 10.1093/oxfordjournals.aje.a119535. [DOI] [PubMed] [Google Scholar]
  27. Kurtzke J. F. A reassessment of the distribution of multiple sclerosis. Part one. Acta Neurol Scand. 1975 Feb;51(2):110–136. doi: 10.1111/j.1600-0404.1975.tb01364.x. [DOI] [PubMed] [Google Scholar]
  28. Kurtzke J. F., Bui-Quoc-Huong Multiple sclerosis in a migrant population: 2. Half-orientals immigrating in childhood. Ann Neurol. 1980 Sep;8(3):256–260. doi: 10.1002/ana.410080306. [DOI] [PubMed] [Google Scholar]
  29. Kurtzke J. F., Dean G., Botha D. P. A method for estimating the age at immigration of white immigrants to South Africa, with an example of its importance. S Afr Med J. 1970 Jun 6;44(23):663–669. [PubMed] [Google Scholar]
  30. Kurtzke J. F. Epidemiologic contributions to multiple sclerosis: an overview. Neurology. 1980 Jul;30(7 Pt 2):61–79. doi: 10.1212/wnl.30.7_part_2.61. [DOI] [PubMed] [Google Scholar]
  31. Kurtzke J. F., Hyllested K. Multiple sclerosis in the Faroe Islands: I. Clinical and epidemiological features. Ann Neurol. 1979 Jan;5(1):6–21. doi: 10.1002/ana.410050104. [DOI] [PubMed] [Google Scholar]
  32. McDonald W. I. Doyne lecture. The significance of optic neuritis. Trans Ophthalmol Soc U K. 1983;103(Pt 3):230–246. [PubMed] [Google Scholar]
  33. McDonald W. I. Multiple sclerosis: the present position. Acta Neurol Scand. 1983 Aug;68(2):65–76. doi: 10.1111/j.1600-0404.1983.tb04819.x. [DOI] [PubMed] [Google Scholar]
  34. Misra U. K., Nag D., Misra N. K., Murti C. R. Macular degeneration associated with chronic pesticide exposure. Lancet. 1982 Jan 30;1(8266):288–288. [PubMed] [Google Scholar]
  35. Morgan B. P., Campbell A. K., Compston D. A. Terminal component of complement (C9) in cerebrospinal fluid of patients with multiple sclerosis. Lancet. 1984 Aug 4;2(8397):251–254. doi: 10.1016/s0140-6736(84)90298-8. [DOI] [PubMed] [Google Scholar]
  36. POSKANZER D. C., SCHAPIRA K., MILLER H. MULTIPLE SCLEROSIS AND POLIOMYELITIS. Lancet. 1963 Nov 2;2(7314):917–921. doi: 10.1016/s0140-6736(63)90624-x. [DOI] [PubMed] [Google Scholar]
  37. PRATT R. T. C., COMPSTON N. D., McALPINE D. The familial incidence of disseminated sclerosis and its significance. Brain. 1951;74(2):191–232. doi: 10.1093/brain/74.2.191. [DOI] [PubMed] [Google Scholar]
  38. Pandey J. P., Goust J. M., Salier J. P., Fudenberg H. H. Immunoglobulin G heavy chain (Gm) allotypes in multiple sclerosis. J Clin Invest. 1981 Jun;67(6):1797–1800. doi: 10.1172/JCI110220. [DOI] [PMC free article] [PubMed] [Google Scholar]
  39. Panitch H. S., Francis G. S. T-lymphocyte subsets in cerebrospinal fluid in multiple sclerosis. N Engl J Med. 1982 Aug 26;307(9):560–561. doi: 10.1056/nejm198208263070921. [DOI] [PubMed] [Google Scholar]
  40. Phadke J. G., Best P. V. Atypical and clinically silent multiple sclerosis: a report of 12 cases discovered unexpectedly at necropsy. J Neurol Neurosurg Psychiatry. 1983 May;46(5):414–420. doi: 10.1136/jnnp.46.5.414. [DOI] [PMC free article] [PubMed] [Google Scholar]
  41. Pinching A. J. Clinical testing of olfaction reassessed. Brain. 1977 Jun;100(2):377–388. doi: 10.1093/brain/100.2.377. [DOI] [PubMed] [Google Scholar]
  42. Poskanzer D. C., Prenney L. B., Sheridan J. L., Kondy J. Y. Multiple sclerosis in the Orkney and Shetland Islands. I: Epidemiology, clinical factors, and methodology. J Epidemiol Community Health. 1980 Dec;34(4):229–239. doi: 10.1136/jech.34.4.229. [DOI] [PMC free article] [PubMed] [Google Scholar]
  43. Poskanzer D. C., Terasaki P. I., Prenney L. B., Sheridan J. L., Park M. S. Multiple sclerosis in the Orkney and Shetland Islands. III: Histocompatibility determinants. J Epidemiol Community Health. 1980 Dec;34(4):253–257. doi: 10.1136/jech.34.4.253. [DOI] [PMC free article] [PubMed] [Google Scholar]
  44. Raff M. C., Fields K. L., Hakomori S. I., Mirsky R., Pruss R. M., Winter J. Cell-type-specific markers for distinguishing and studying neurons and the major classes of glial cells in culture. Brain Res. 1979 Oct 5;174(2):283–308. doi: 10.1016/0006-8993(79)90851-5. [DOI] [PubMed] [Google Scholar]
  45. Raff M. C., Miller R. H., Noble M. A glial progenitor cell that develops in vitro into an astrocyte or an oligodendrocyte depending on culture medium. Nature. 1983 Jun 2;303(5916):390–396. doi: 10.1038/303390a0. [DOI] [PubMed] [Google Scholar]
  46. Ritchie A. W., Oswald I., Micklem H. S., Boyd J. E., Elton R. A., Jazwinska E., James K. Circadian variation of lymphocyte subpopulations: a study with monoclonal antibodies. Br Med J (Clin Res Ed) 1983 Jun 4;286(6380):1773–1775. doi: 10.1136/bmj.286.6380.1773. [DOI] [PMC free article] [PubMed] [Google Scholar]
  47. Rutherford W. H. Sequelae of concussion caused by minor head injuries. Lancet. 1977 Jan 1;1(8001):1–4. doi: 10.1016/s0140-6736(77)91649-x. [DOI] [PubMed] [Google Scholar]
  48. Schröder R., Zander H., Andreas A., Mauff G. Multiple sclerosis: immunogenetic analyses of sib-pair double case families. II. Studies on the association of multiple sclerosis with C2, C4, BF, C3, C6, and GLO polymorphisms. Immunobiology. 1983 Mar;164(2):160–170. doi: 10.1016/S0171-2985(83)80007-2. [DOI] [PubMed] [Google Scholar]
  49. Soudek D. Gregor Mendel and the people around him (commemorative of the centennial of Mendel's death). Am J Hum Genet. 1984 May;36(3):495–498. [PMC free article] [PubMed] [Google Scholar]
  50. Spielman R. S., Nathanson N. The genetics of susceptibility to multiple sclerosis. Epidemiol Rev. 1982;4:45–65. doi: 10.1093/oxfordjournals.epirev.a036251. [DOI] [PubMed] [Google Scholar]
  51. Stewart G. J., Basten A., Kirk R. L. Strong linkage disequilibrium between HLA-Dw2 and and BfS in multiple sclerosis and in the normal population. Tissue Antigens. 1979 Aug;14(2):86–97. doi: 10.1111/j.1399-0039.1979.tb00827.x. [DOI] [PubMed] [Google Scholar]
  52. Stewart G. J., McLeod J. G., Basten A., Bashir H. V. HLA family studies and multiple sclerosis: A common gene, dominantly expressed. Hum Immunol. 1981 Aug;3(1):13–29. doi: 10.1016/0198-8859(81)90040-9. [DOI] [PubMed] [Google Scholar]
  53. Ten days of democracy. Br Med J. 1978 Jul 29;2(6133):310–310. [PMC free article] [PubMed] [Google Scholar]
  54. Traugott U., Reinherz E. L., Raine C. S. Multiple sclerosis: distribution of T cell subsets within active chronic lesions. Science. 1983 Jan 21;219(4582):308–310. doi: 10.1126/science.6217550. [DOI] [PubMed] [Google Scholar]
  55. Uno H., Sasazuki T., Tamai H., Matsumoto H. Two major genes, linked to HLA and Gm, control susceptibility to Graves' disease. Nature. 1981 Aug 20;292(5825):768–770. doi: 10.1038/292768a0. [DOI] [PubMed] [Google Scholar]
  56. Watanabe R., Wege H., ter Meulen V. Adoptive transfer of EAE-like lesions from rats with coronavirus-induced demyelinating encephalomyelitis. Nature. 1983 Sep 8;305(5930):150–153. doi: 10.1038/305150a0. [DOI] [PMC free article] [PubMed] [Google Scholar]
  57. Whittingham S., Mathews J. D., Schanfield M. S., Tait B. D., Mackay I. R. Interaction of HLA and Gm in autoimmune chronic active hepatitis. Clin Exp Immunol. 1981 Jan;43(1):80–86. [PMC free article] [PubMed] [Google Scholar]

Articles from Journal of Neurology, Neurosurgery, and Psychiatry are provided here courtesy of BMJ Publishing Group

RESOURCES